Actually your post makes a lot of sense. I will be "front-running" on the close today and tomorrow. looks like "easy money" if there is such a thing anymore. I don't see the shorts wanting to hold on once the clinical trial data starts to come out, so next week could see some substantial short covering. I will get ahead of it.
Pretty quiet until the new year THEN meetings, clinical trial results and someday a corporate deal to put RC on the map. It's one he11 of a buy at these tax-selling distressed prices.
A good, disruptive anti-inflammatory, at this stage (WITH NO BAGGAGE) would be worth, $350MM - $500MM. Do the math, that's a big number for this little company. Were it not for the baggage (now discarded) we would be so much higher. Thank you, Jonnie, Paul, Curtis, Christopher, etal, you really skrewed the pooch.